GlassScriptPhysician profile
Ryan O'Kelley
NPI 1871887489
$8,194.89
in general payments reported to CMS, 2019-2025
31 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,399 · 2020: $1,246 · 2021: $880 · 2022: $1,169 · 2023: $1,205 · 2024: $2,014 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,500.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,739.11 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ge Healthcare | $1,443.83 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $913.03 | 2020-2022 | |
| Angiodynamics, INC. | $778.32 | 2020-2024 | Auryon Laser System 100-120 Vac, Alphavac |
| Endologix LLC | $701.42 | 2021-2022 | |
| Stryker Corporation | $678.82 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Trevo |
| Depuy Synthes Sales INC. | $421.40 | 2022-2024 | Embotrap, Cerepak Uniform, Cerebase |
| W. L. Gore & Associates, INC. | $343.27 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Imperative Care, INC | $168.32 | 2022-2024 | Zoom Rdl Radial Access System, 103cm, Zoom 88-T Large Distal Platform |
| Medtronic Vascular, INC. | $144.34 | 2019-2020 | |
| Philips North America LLC | $142.90 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $94.90 | 2021-2024 | Artis Icono Biplane |
| Medtronic, INC. | $67.49 | 2022-2025 | Osteocool Rf Ablation System, Endurant Iis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.30 | 2022-2024 | Lifevest |
| Boston Scientific Corporation | $52.46 | 2022-2025 | Varithena Administration Pack |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $49.74 | 2019-2020 | |
| Edwards Lifesciences Corporation | $49.01 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cardiva Medical, INC. | $47.95 | 2021 | |
| Teleflex LLC | $40.95 | 2019-2023 | Vsi |
| Cook Medical LLC | $40.70 | 2020-2021 | |
| Terumo Medical Corporation | $40.03 | 2022-2023 | Metacross Otw, Progreat |
| Silk Road Medical, INC. | $28.44 | 2021 | |
| Smith+Nephew, INC. | $23.38 | 2020 | |
| Trisalus Life Sciences, INC. | $20.68 | 2021 | |
| Cvrx, INC. | $20.48 | 2022 | |
| Shockwave Medical, INC | $16.47 | 2022 | |
| Abbott Laboratories | $15.70 | 2024 | Jeti All In One Non-Sterile Kit |
| Ekos Corporation | $13.44 | 2019 | |
| Medtronic USA, INC. | $13.37 | 2020 | |
| Lemaitre Vascular, INC. | $13.12 | 2022 | |
| Scientia Vascular | $11.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan O'Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.